CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: To Demonstrate the Relative Bioavailability of Atenolol Tablets [Phase 1]
Summary
A Phase 1 study sponsored by Sandoz evaluated the relative bioavailability of atenolol tablets in hypertension and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED